SARS-CoV-2 Membrane GP_2 A2 (HLA-A*02:01)
( SLVKPSFYV )
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike protein (S) and others. The membrane glycoprotein is present on the coronavirus envelope and it has an important role in virion assembly. SARS-CoV-2 Membrane GP_2 A2 (HLA-A*02:01) is a linear peptidic epitope studied as part of membrane glycoprotein from severe acute respiratory syndrome-related coronavirus. Based on recent studies, this sequence is one of the most promised MHC class I related peptides in envelope protein based vaccine of COVID-19.
| Sequence: | SLVKPSFYV | |
| Delivery: | 2-3 days | |
| C-Terminus: | OH | |
| N-Terminus: | H | |
| Amount: | 1 mg | |
| Counter Ion: | TFA | |
| Species: | SARS-CoV-2 | |
| Allele: | HLA-A*02:01 | |
| Application : | Flow Cytometry | |
| Indication : | Coronavirus(COVID-19) | |
| Purity : | 95% HPLC-MS |
Protocols and Tips
Data sheets
Safety data sheet poly peptides:For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
€96.60*
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS